Revenue Growth Expectations: The transdermal drug delivery systems market is expected to reach USD 7.1 billion by 2023 from an estimated USD 5.7 billion in 2018, at a CAGR of 4.5% during the forecast period (2018-2023). Growth Boosting Factors: Market growth is largely driven by the global increase in the prevalence of chronic diseases. In addition, technological advancements in transdermal drug..